VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 51 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144 | -57.0% | 18,600 | -36.5% | 0.00% | 0.0% |
| Q2 2023 | $335 | -99.9% | 29,300 | -78.0% | 0.00% | -50.0% |
| Q1 2021 | $627,000 | +13.6% | 133,200 | +72.3% | 0.00% | 0.0% |
| Q4 2020 | $552,000 | +34.0% | 77,300 | +99.7% | 0.00% | 0.0% |
| Q3 2020 | $412,000 | -15.6% | 38,700 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $488,000 | +17.6% | 38,700 | -14.8% | 0.00% | 0.0% |
| Q1 2020 | $415,000 | -34.4% | 45,400 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $633,000 | -48.7% | 45,400 | -36.8% | 0.00% | 0.0% |
| Q3 2019 | $1,234,000 | +115.0% | 71,800 | +240.3% | 0.00% | 0.0% |
| Q2 2019 | $574,000 | – | 21,100 | – | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2016 | $75,000 | -46.0% | 5,900 | -49.1% | 0.00% | -100.0% |
| Q3 2016 | $139,000 | +6.1% | 11,600 | -3.3% | 0.00% | 0.0% |
| Q2 2016 | $131,000 | +718.8% | 12,000 | +531.6% | 0.00% | – |
| Q1 2016 | $16,000 | -61.0% | 1,900 | 0.0% | 0.00% | – |
| Q4 2015 | $41,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
| Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
| GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
| BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
| Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
| Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
| Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
| Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
| THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |